Isolation and comparison of tumorigenicity of different cell populations from the MCF-7 breast cancer cell line based on CD44 and CD24 markers
Author affiliations
DOI:
https://doi.org/10.15625/1811-4989/9/1/1072Keywords:
Breast cancer cells, MCF-7 cell line, Breast cancer stem cells, TumorigenicityAbstract
Breast cancer stem cells are the origin of breast tumour. Cells expressing marker CD44+CD24-/dim were considered breast cancer stem cells in human being. The aims of this study is to isolate potential candidate breast cancer stem cell from the MCF-7 cell line to find out whether it is possible to isolate cancer stem cells using two cell surface markers: CD44 and CD24. Stem-like properties were studied in vivo by observing the tumorigenicity of different cell populations in immunosuppressed mouse models. MCF-7 cells were subculture for several passages and were sorted out into 3 different cell populations by 2 specific antibodies which bind to CD44 and CD24, using flow cytometry. Cell sub-populations: CD44+, CD44+/CD24+ and CD44+/CD24-/dim were further cultured and were then analysed using flow cytometry again to determine the purity of the population. Different cell sub-populations were then harvested and injected into mouse models at two specific doses, 103 and 106 cells. Tumour formation in the mice was monitored closely and the percentages of mice which have tumour were recorded as results. The results showed that the capacity of causing tumour in mouse was highest in CD44+CD24-/dim cell population and lowest in CD44+ cell population. These results confirmed CD44+CD24-/dim cells were the strongest cell population causing tumour in breast cancer cells MCF-7Downloads
Downloads
Published
How to Cite
Issue
Section
License
Vietnam Journal of Biotechnology is a peer-reviewed, open access journal dedicated to the dissemination of scientific knowledge and research findings in the field of biotechnology. All published articles are freely accessible and downloadable by readers worldwide without any subscription or access fees.
All articles published in Vietnam Journal of Biotechnology are distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) License. This license allows users to share, copy, redistribute, adapt, and reproduce the material in any medium or format, provided that appropriate credit is given to the original author(s) and source, and that any derivative works are distributed under the same license terms.
The copyright of each published article remains with the respective author(s) without restriction. By submitting and granting permission for publication through the journal’s submission system or other communication channels, authors authorize Vietnam Journal of Biotechnology to publish and identify itself as the original publisher of the work. Authors also acknowledge and agree to comply with the terms and conditions of the CC BY-SA 4.0 License and the policies established by the journal.
